跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 75 条关于
“Perzea”
全部
75
临床试验
56
药物
1
机构
5
资讯
13
12个月前
Hetero Healthcare and Enzene Launch Perzea, India's Most Affordable Pertuzumab Biosimilar for HER2-Positive Breast Cancer
25天前
Ashland launches permexa™ sodium caprate to advance oral biologics delivery
10个月前
FDA Approves First Perjeta Biosimilar as Shanghai Henlius and Organon Secure Interchangeable Status
去年
Henlius and Organon's HLX11 Biosimilar Meets Primary Endpoint in Phase 3 Breast Cancer Trial
上个月
Roche Canada and pCPA Complete Negotiations for Perjeta in Neoadjuvant HER2-Positive Early Breast Cancer
去年
PERLA Trial Update: Sintilimab Plus Chemotherapy Shows Sustained Survival Benefit in NSCLC
5年前
EMA Committee Backs Roche's Phesgo, A Novel Subcutaneous Combination of Herceptin and Perjeta for HER2+ Breast Cancer
去年
FDA Clears Spineart's PERLA® App for Use with eCential Robotics' Op.n™ Navigation Platform
去年
Ten-Year APHINITY Data Shows Perjeta-Based Regimen Reduces Death Risk by 17% in HER2-Positive Early Breast Cancer
去年
Pediatric Drug Testing Under PREA: An Analysis of Drugs Approved 2015-2021
第 1 页,共 2 页
上一页
下一页